Literature DB >> 16509586

Molecular evolution of adrenoceptors and dopamine receptors: implications for the binding of catecholamines.

Henri Xhaard1, Ville-Veikko Rantanen, Tommi Nyrönen, Mark S Johnson.   

Abstract

We derived homology models for all human catecholamine-binding GPCRs (CABRs; the alpha-1, alpha-2, and beta-adrenoceptors and the D1-type and D2-type dopamine receptor) using the bovine rhodopsin-11-cis-retinal X-ray structure. Interactions were predicted from the endogenous ligands norepinephrine or dopamine and from the binding site and were used to optimize receptor-ligand interactions. Similar binding modes in the complexes agree with a large "binding core" conserved across the CABRs, that is, D3.32, V(I)3.33, T3.37, S5.42, S(A/C)5.43, S5.46, F6.51, F6.52, and W6.48. Model structures and docking simulations suggest that extracellular loop 2 could provide a common attachment point for the ligands' beta-hydroxyl via a hydrogen bond donated by the main-chain NH group of residue xl2.52. The modeled CABRs and docking modes are in good agreement with published experimental studies. Complementarity between the ligand and the binding site suggests that the bovine rhodopsin structure is a suitable template for modeling agonist-bound CABRs.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16509586     DOI: 10.1021/jm0511031

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  17 in total

1.  FFA1-selective agonistic activity based on docking simulation using FFA1 and GPR120 homology models.

Authors:  Masato Takeuchi; Akira Hirasawa; Takafumi Hara; Ikuo Kimura; Tatsuya Hirano; Takayoshi Suzuki; Naoki Miyata; Takeo Awaji; Masaji Ishiguro; Gozoh Tsujimoto
Journal:  Br J Pharmacol       Date:  2013-04       Impact factor: 8.739

2.  High-resolution cardiovascular function confirms functional orthology of myocardial contractility pathways in zebrafish.

Authors:  Jordan T Shin; Eugene V Pomerantsev; John D Mably; Calum A MacRae
Journal:  Physiol Genomics       Date:  2010-04-13       Impact factor: 3.107

3.  Engineering a GPCR-ligand pair that simulates the activation of D(2L) by Dopamine.

Authors:  Nuska Tschammer; Miriam Dörfler; Harald Hübner; Peter Gmeiner
Journal:  ACS Chem Neurosci       Date:  2009-09-24       Impact factor: 4.418

4.  Eleven new putative aminergic G-protein coupled receptors from Amphioxus (Branchiostoma floridae): identification, sequence analysis and phylogenetic relationship.

Authors:  Chloe Burman; Braudel Maqueira; John Coadwell; Peter D Evans
Journal:  Invert Neurosci       Date:  2007-01-16

5.  Involvement of the first transmembrane segment of human α(2) -adrenoceptors in the subtype-selective binding of chlorpromazine, spiperone and spiroxatrine.

Authors:  J M M Laurila; G Wissel; H Xhaard; J O Ruuskanen; M S Johnson; M Scheinin
Journal:  Br J Pharmacol       Date:  2011-11       Impact factor: 8.739

6.  Amphioxus expresses both vertebrate-type and invertebrate-type dopamine D(1) receptors.

Authors:  Chloe Burman; Peter D Evans
Journal:  Invert Neurosci       Date:  2010-11-27

7.  GPCR agonist binding revealed by modeling and crystallography.

Authors:  Vsevolod Katritch; Ruben Abagyan
Journal:  Trends Pharmacol Sci       Date:  2011-09-06       Impact factor: 14.819

8.  Analysis of full and partial agonists binding to beta2-adrenergic receptor suggests a role of transmembrane helix V in agonist-specific conformational changes.

Authors:  Vsevolod Katritch; Kimberly A Reynolds; Vadim Cherezov; Michael A Hanson; Christopher B Roth; Mark Yeager; Ruben Abagyan
Journal:  J Mol Recognit       Date:  2009 Jul-Aug       Impact factor: 2.137

9.  On the applicability of GPCR homology models to computer-aided drug discovery: a comparison between in silico and crystal structures of the beta2-adrenergic receptor.

Authors:  Stefano Costanzi
Journal:  J Med Chem       Date:  2008-04-29       Impact factor: 7.446

10.  Structural basis of the selectivity of the beta(2)-adrenergic receptor for fluorinated catecholamines.

Authors:  Chaya Pooput; Erica Rosemond; Joel Karpiak; Francesca Deflorian; Santiago Vilar; Stefano Costanzi; Jürgen Wess; Kenneth L Kirk
Journal:  Bioorg Med Chem       Date:  2009-10-13       Impact factor: 3.641

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.